Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0522213468
Mon, 20.06.2022
Achiko AG
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by 26 June 2022
Zurich, 20 June 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that Achiko will publish its annual report and its annual financial statements for the [ … ]
Fri, 10.06.2022
Achiko AG
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by 20 June 2022
Zurich, 10 June 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that Achiko will publish its annual report and its annual financial statements for the [ … ]
Mon, 06.06.2022
Achiko AG
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by 10 June 2022
Zurich, 6 June 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that Achiko will publish its annual report and its annual financial statements for the ye [ … ]
Tue, 31.05.2022
Achiko AG
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by 6 June 2022
Zurich, 31 May 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that Achiko will publish its annual report and its annual financial statements for the yea [ … ]
Wed, 25.05.2022
Achiko AG
Achiko AG Secures CHF 1.25 million Financing with Strategic Investors Buranto AG and Negma Group
- Buranto AG provided a CHF 250,000 loan facility and existing strategic investor Negma Group provided a CHF 1.0 million loan facility
- Derek Brandt, co-owner of Buranto AG, joins Achiko’s Advisory Board
- Funds to be used for production in Indones [ … ]
Thu, 19.05.2022
Achiko AG
Achiko AG Reports Key Unaudited Financial Results for the Year Ended 31 December 2021
- Full year unaudited adjusted EBITDA loss [corrected] of USD$5,272,179 (2020: USD$8,728,709 loss) following 6 months unaudited loss of USD$3,915,136 to 30 June 2021 and closing Shareholders Equity of USD($4,297,969) (2020: USD$4,052,073).
- Restructuring of th [ … ]
Thu, 19.05.2022
Achiko AG
Achiko AG Reports Key Unaudited Financial Results for the Year Ended 31 December 2021
- Full year unaudited adjusted EBITDA of USD$5,272,179 (2020: USD$8,728,709) following 6 months unaudited of USD$3,915,136 to 30 June 2021 and closing Shareholders Equity of USD$4,297,969 (2020: $4,052,073).
- Restructuring of the European operations in mid-202 [ … ]
Tue, 17.05.2022
Achiko AG
Achiko AG Obtains CE Mark for AptameXTM Covid-19 Rapid Test
- Registered AptameX and has obtained a CE Mark, allowing the product to be sold in 27 countries in the EU
- AptameX has unique performance advantages over other rapid tests through its use of DNA aptamers
- The Company expects to have AptameX in widespread commercial availability in Q [ … ]
Fri, 29.04.2022
Achiko AG
Achiko AG - Publication of Annual Report and Annual Financial Statements 2021 to Occur by 31 May 2022
Zurich, 29 April 2022: Ad hoc announcement pursuant to Art. 53 LR - Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) ("Achiko", the "Company") announces that Achiko will publish its annual report and its annual financial statements for the y [ … ]
Thu, 28.04.2022
Achiko AG
AptameX Production and Commercialisation Update
- Company has commenced shipping and will book first sales in May 2022
- Reorganised production line able to meet stronger than expected demand for Achiko AG's innovative DNA aptamer saliva-based rapid test for Covid-19
- Validated calibration through quality control tests completed in Taiwan and [ … ]